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Abstract
Background: Pregnant women are more susceptible to severe Plasmodium falciparum malaria, which can lead to
poor maternal and fetal outcomes. Few data exist on the epidemiology of severe P. falciparum malaria in pregnant
women.
A hospital-based study was carried out to assess the pattern of severe P. falciparum malaria among pregnant
women at the Kassala and Medani maternity hospitals, which are located in areas of unstable malaria transmission,
in eastern and central Sudan, respectively. Pre-tested questionnaires were used to gather socio-demographic,
clinical and obstetrical data. Suitable tests were performed for clinical and biochemical investigations.
Results: Among 222 pregnant women diagnosed with malaria at the two hospitals, 40 (18.0%) women at mean
(SD) gestational age of 29.3 (6.7) weeks fulfilled one or more of the WHO criteria for severe P. falciparum malaria.
These were hypoglycaemia (14; 35.5%), severe anaemia (12; 30%), hypotension (10; 25%), jaundice (9; 22.5%),
cerebral malaria (6; 15%), repeated convulsions (4; 10%), hyperparasitaemia (4; 10.0%) and more than one
manifestation (9; 22.5%). While the mean (SD) presenting temperature was significantly lower for women
presenting with hypoglycaemia [38.2(0.6) versus 38.8(0.7) °C, P = 0.04], other clinical and biochemical characteristics
were not significantly different among women with different manifestations of severe P. falciparum malaria.
Conclusion: Preventive measures for pregnant women such as insecticide-treated bednets and chemoprophylaxis
may be beneficial in areas of unstable malaria transmission. Early detection and prompt treatment of severe
malaria, especially in pregnant women with hypoglycaemia, are needed.
Background
Malaria in pregnancy is a major public health problem
in tropical and subtropical regions of the world. In
Africa, millions of women living in malaria-endemic
areas become pregnant each year [1,2]. Malaria in preg-
nancy contributes to significant maternal and perinatal
morbidity and mortality. Each year, more than 500,000
women die during pregnancy or childbirth [1]. Severe
malaria is a medical emergency associated with high
mortality, especially in cases with multiple organ dys-
function [3]. Cerebral malaria and severe malarial
anaemia are two major syndromes causing malaria-
related mortality [4]. Children and pregnant women
are the most vulnerable groups to the severe form of
P. falciparum malaria [3]. While much literature and
many publications are available on severe malaria in
children, few published data exist on severe malaria
during pregnancy [5]. Pregnant women are more
attractive to the main malaria vector and the disease,
including its severe form, than their non-pregnant
counterparts [6-8]. Understanding the interactions that
underlie the disease and its control should be helpful
to investigate the epidemiology of severe malaria. Thus,
such study is vital and may be of great interest for pro-
viding health planners and caregivers with fundamental
guidelines for the implementation of preventive
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maternal and perinatal mortality have been observed in
different regions, and both malaria and anaemia were
the major causes of these high levels of mortality
[9-11].
Thus, the present study was conducted at the Kassala
and Medani maternity hospitals in Sudan, which are
located in areas characterized by unstable malaria trans-
mission [12], and where malaria is a substantial burden
affecting pregnant women irrespective of their age or
parity [13].
Methods
This study was conducted at the Kassala and Medani
(Figure 1) maternity hospitals in Sudan during the period
from July to November 2010 for investigating the
epidemiology of severe P. falciparum malaria among
pregnant women. Pregnant women with symptoms of
P. falciparum malaria were included in this study after
informed consent was obtained from the patient or guar-
dian. Those women with one or more of the manifesta-
tions of severe P. falciparum malaria according to the
World Health Organization (WHO) criteria, which
include cerebral malaria (unarousable coma), convulsion
(more than two per 24 hours), hypotension (systolic
blood pressure < 90 mmHg with cold extremities), severe
anaemia (haemoglobin < 7 gm/dl), jaundice (detected
clinically or bilirubin > 1 mg/dl), hypoglycaemia (blood
glucose < 40 mg/dl) and hyperparasitaemia (parasite
count > 100,000 ring forms/μl), were managed accord-
ing to the WHO guidelines, and the rest were consid-
ered as uncomplicated cases [3]. Questionnaires were
used to gather socio-demographic, medical and obste-
trical data.
Blood films were prepared and stained with Giemsa,
and 100 oil immersion fields were examined. The para-
site density was evaluated by counting the number of
asexual P. falciparum parasites for every 200 leuko-
cytes, assuming a leukuocyte count of 8000 leukocytes/
μl. All slides were double-checked in a blinded manner
and only considered negative if no parasites were
detected in 100 oil immersion fields. If gametocytes
were seen, then the count was extended to 500 oil
immersion fields. Haemoglobin concentrations were
estimated using a HemoCue haemoglobinometer
(HemoCue AB, Angelhom, Sweden). Blood glucose was
measured at baseline before quinine infusion, two
hours after quinine infusion and if there was clinical
suspicion of hypoglycaemia using the bedside device
Accu-Chek™ Multiclix (Roche diagnostics, Mannheim
Germany). The Accu-Chek™ machine was calibrated
weekly and every time a new box of test strips was
opened.
Resuscitation and supportive management were given
according to the WHO guidelines [3]; i.e. quinine infusion
at 10 mg/kg three times a day over 2-3 hours changed to
oral quinine tablet when the patient could tolerate them,
correction of hypoglycaemia with 10% glucose, termina-
tion of convulsions with intravenous diazepam if they
were persisting for more than three minutes. Paracetamol
was given every 6 hours until defervescence. Those with
severe anaemia (haemoglobin < 7 g/dl) and respiratory dis-
tress were transfused with blood screened for hepatitis and
HIV. Vital signs were measured every 15 minutes for the
first hour, then every 2 hours until 24 hours, and there-
after every 6 hours until the discharge from the hospital.
Baseline investigations were performed for every patient
on admission and repeated when clinically indicated.
These included levels of haemoglobin, serum urea, serum
creatinine, and serum bilirubin as well as the white blood
cell count.
Statistics
Data were entered into a computer database and SPSS
software (SPSS Inc., Chicago, IL, USA) and double
checked before analysis. Means (SD) and proportions
for the socio-demographic and biochemical variables
were calculated. ANOVA was used to compare the
means (SD) between the different groups of severe
malaria. Correlations between the different continuous
clinical and biochemical variables were calculated. P <
0.05 was considered significant.
Figure 1 Map showing different regions of Sudan.
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Results
Among 222 pregnant women diagnosed with malaria at
the two hospitals, 40 (18.0%) fulfilled one or more of
the WHO criteria for severe P. falciparum malaria.
These were hypoglycaemia (14; 35.5%), severe anaemia
(12; 30%), hypotension (10; 25%), jaundice (9; 22.5%),
cerebral malaria (6; 15%), repeated convulsions (4; 10%),
hyperparasitaemia (4; 10.0%) and more than one mani-
festation (9; 22.5%), Table 1. Ten patients with severe
anaemia received blood transfusion. Out the 12 patients
with severe anaemia; three patients (25%) had jaundice,
one patient had hypotension and hyperparasitaemia
(parasite count was 133333 rings/μ) and one patient had
hypogylcaemia. The mean (SD) of the age, gravidity and
gestational age of these 40 women were 28.4 (6.1) years,
3.5 (2.3) and 29.3 (6.7) weeks, respectively, Table 2. The
parity ranged from 1 to 9, (median = 2) and 10 (25%) of
these women were primigravidae. None of the patients
had used antimalarial chemoprophylaxis. There were no
maternal deaths. All women were febrile. Different
symptoms such as sweating, aches, vomiting and diar-
rhoea were observed among these women, Figure 2.
None of the patients developed hypoglycaemia during
quinine treatment. All patients started oral quinine
tablet within two days.
While the mean (SD) presenting temperature was sig-
nificantly lower in women presenting with hypoglycae-
mia [38.2(0.6) versus 38.8(0.7) °C, P = 0.04], other
clinical and biochemical characteristics were not signifi-
cantly different among women with different manifesta-
tions of severe P. falciparum malaria, Table 3. The
haemoglobin level was significantly lower in the anaemic
group, Table 3. There was no significant correlation
between blood glucose levels and temperature, haemo-
globin levels and parasite counts, Table 4.
Discussion
The main findings of the present study were that hypo-
glycaemia and severe anaemia were the predominant
presenting manifestations of severe P. falciparum
malaria observed during pregnancy in this epidemiologi-
cal setting. With the exception of lower temperatures,
other clinical and biochemical criteria were not different
among women with different criteria of severe P. falci-
parum malaria. Previously, severe anaemia and jaundice
had been observed as the presenting manifestations of
severe P. falciparum malaria in pregnant women in cen-
tral and eastern Sudan [5,14]. In neighbouring Ethiopia,
cerebral malaria, convulsions, altered mental state and
prostration were the common manifestations of severe
malaria observed in pregnant women [15]. Generally,
pregnant women are more susceptible to severe malaria
and hypoglycaemia than their non-pregnant peers [3,7].
The glucose metabolism during malaria infection is
affected by several factors, including drug treatment,
fever, parasite metabolism, hormonal changes, cytokines,
fasting and gastrointestinal disturbances [16,17]. It has
been reported that patients with severe malaria-induced
hypoglycaemia have higher mortality rates [18]. Thus,
the recognition of patients with falciparum malaria and
hypoglycaemia by blood glucose estimation at the time
of admission could significantly affect the ultimate out-
come. Interestingly, some comatose patients regained
consciousness with intravenous fluid infusion of 25%
dextrose only without receiving any specific antimalarial
treatment [18]. None of these patients developed hypo-
glycaemia after quinine treatment. In this study blood
glucose was investigated at base line, two hours follow-
ing quinine and if hypoglycaemia was clinically
suspected. Ideally, blood glucose should be investigated
every four hours if possible especially in comatose
patients according to the WHO guidelines [19].
Table 1 presentations of severe P. falciparum malaria at
Kassala and Medani Maternity Hospitals, Sudan
Criteria of severe P. falciparum
malaria
Number of
women
Percentage
Hypoglycaemia 14 35.5
Severe anaemia 12 30.0
Hypotension 10 25.0
Jaundice 9 22.5
Cerebral malaria 6 15.0
Convulsions 4 10.0
Hyperparasitaemia 4 10.0
More than one complication 9 22.5
Table 2 presenting clinical and biochemical data of the
pregnant women with severe P. falciparum malaria at
Kassala and Medani Maternity Hospitals, Sudan
Variables range, mean ± SD
Age, years 28.4 ± 6.1 [18–40]
Gravidity 3.5 ± 2.3 [1–9]
Gestational age, weeks 29.3 ± 6.7 [14–38]
Duration of illness, days 2.5 ± 1.1 [1–6]
Weight, kg 59.3 ± 7.1 [43–75]
Temperature, °c 38.5 ± 0.7 [37.8–40.0]
Haemoglobin, gm/dl 8.3 ± 1.7 [5–11.0]
White blood cells, cell/mm
3 6300 ± 2927 [2700–14000]
Parasite count, rings/μl 30717 ± 5270 [2080–335242]
Blood glucose, mg/dl 71.4 ± 3.0 [29–120]
serum bilirubin, mg/dl 2.0 ± 0.7 [1–3]
Serum creatinine, mg/dl 1.0 ± 0.2 [0.7–2.0]
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where quinine -induced hypoglycaemia was not investi-
gated as should be. Previously, only one out of 33 preg-
nant Sudanese women developed hypoglycaemia
following quinine treatment for severe P. falciparum
malaria [5]. Hyperinsulinaemic hypoglycaemia is the
most important adverse effect in the quinine treatment
of severe malaria which is particularly common in preg-
nancy (50% of quinine-treated women with severe
malaria in late pregnancy) [20,21]. Intravenous artesu-
nate is superior to quinine in the treatment of severe
malaria [22]. Compared to intravenous quinine, intrave-
nous artesunate has been shown to have; a lower risk of
hypoglycaemia, significantly reduce the risk of death
from severe malaria, and it is not requiring rate con-
trolled infusion or cardiac monitoring [19]. Patients in
this series were in their second and third trimester of
pregnancy; therefore intravenous artesunate would have
been given to these women instead of quinine. However,
intravenous artesunate is not yet registered and available
in Sudan.
In the present study, 12 (30%) and 6 (15%) patients
presented with severe anaemia and cerebral malaria,
respectively. Cerebral malaria and severe malarial
anaemia are two major syndromes causing malaria-
related mortality [4]. The pattern of these two severe
forms varies depending on the intensity of transmission;
cerebral malaria is more common in older children in
areas with lower intensity of transmission, whereas
severe malarial anaemia is often seen in children below
two years of age in areas with intense transmission [4].
Maternal anaemia and malaria have been reported in
areas of unstable malaria transmission in Thailand and
in Ethiopia, as well as in areas of stable malaria trans-
mission [23,24]. Regardless of the transmission level and
the level of pre-pregnancy immunity against malaria,
maternal anaemia remains the most frequent conse-
quence of malaria during pregnancy [25]. Interestingly,
we have recently observed a high prevalence of anaemia
in pregnant women in these two hospitals and anaemic
women were at a higher risk of stillbirth and low birth
weight deliveries [26-29]. Interestingly, seven out 12
patients in the current study had severe anaemia with-
out evidence of multiorgan dysfunction or other mani-
festations of severe of malaria. Although, these patients
fulfilled the WHO criteria for severe malaria [3], per-
haps some of these women had severe anaemia and con-
current uncomplicated malaria rather than severe
P. falciparum malaria. Thus, in such situation these
patients would have received blood transfusion and
artemisinins combination therapy rather than quinine
treatment.
There were no maternal deaths in this study, early
diagnosis; prompt effective treatment could explain this
observation. These women would appear to represent a
milder spectrum of disease e.g. severe anaemia and
hypotension. It have been shown that, within the broad
definition of severe P. falciparum malaria there are syn-
dromes associated with mortality rates that are lower
(e.g. severe anaemia) and higher (cerebral malaria and
metabolic acidosis) [19]. We previously observed that
malaria was one of the main causes of high maternal
mortality in these two hospitals [9,30]. Maternal mortal-
ity is approximately 50% in pregnant women with severe
P. falciparum malaria, which is higher than in non-
Figure 2 Presenting symptoms among pregnant women with
severe P. falciparum malaria.
Table 3 comparison of clinical and biochemical data in the subgroups of the pregnant women with severe
P. falciparum malaria at Kassala and Medani Maternity Hospitals, Sudan
Variable Hypoglycemic group (N = 14) Anaemic group (N = 12) Other group
(N = 14)
P
Age, years 27.1(8.1) 30.1(5.9) 28.8(4.4) 0.1
Gravidity 3.8(2.9) 3.6(2.7) 3.5(1.9) 0.3
Gestational age, weeks 26.9(6.4) 29.2(8.4) 32.0(4.5) 0.6
Weight, kg 59.0(6.6) 61.3(7.7) 58.3(7.6) 0.2
Temperature, °C 38.2(0.6) 38.5(0.5) 38.8(0.7) 0.04
Haemoglobin, gm/dl 8.4(1.4) 6.2(0.7) 9.2(1.1) 0.001
parasite count, ring/μ 32057(62169.1) 27191(37961) 29244(3633) 0.9
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that we could not follow up these women and investi-
gate/report the maternal and perinatal outcomes, and
compare them to women with uncomplicated P. falci-
parum malaria and healthy controls.
Conclusion
Preventive measures for pregnant women such as insec-
ticide-treated bednets and chemoprophylaxis may be
beneficial in areas of unstable malaria transmission.
Early detection and prompt treatment of severe malaria,
especially in pregnant women with hypogylcaemia, are
needed.
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